TriSalus Life Sciences (TLSI) Asset Writedowns and Impairment (2024 - 2025)
TriSalus Life Sciences (TLSI) posted quarterly Asset Writedowns and Impairment of $34000.0 for Q3 2025, down 40.35% quarter-over-quarter from $57000.0 in Q2 2025.
TriSalus Life Sciences (TLSI) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends
TriSalus Life Sciences' Asset Writedowns and Impairment history runs 2 years deep, the most recent figure standing at $34000.0 for Q3 2025.
- In Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to $34000.0; the TTM figure through Sep 2025 stood at $317000.0 (changed N/A YoY), while the FY2024 annual figure was $187000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q3 2025 stood at $34000.0, down from $57000.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $187000.0 in Q4 2024, with the low at $34000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn |
| 10 | TriSalus Life Sciences | 304.89 Mn | 258.60 Mn | 9.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 34,000.00 |
| Sep 30, 2025 | 34,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Jun 30, 2025 | 57,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 187,000.00 |
| Dec 31, 2024 | 187,000.00 |